HomeIRLAB-A • STO
add
IRLAB Therapeutics AB
Previous close
kr 13.10
Day range
kr 12.65 - kr 13.10
Year range
kr 5.58 - kr 20.20
Market cap
678.43M SEK
Avg Volume
20.72K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 9.03M | — |
Operating expense | 3.26M | -69.42% |
Net income | -31.66M | 17.54% |
Net profit margin | -350.55 | — |
Earnings per share | — | — |
EBITDA | -28.22M | 28.85% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 90.38M | -23.93% |
Total assets | 160.29M | -14.24% |
Total liabilities | 122.26M | 213.99% |
Total equity | 38.03M | — |
Shares outstanding | 51.87M | — |
Price to book | 17.95 | — |
Return on assets | -39.17% | — |
Return on capital | -65.78% | — |
Cash Flow
Net change in cash
| (SEK) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -31.66M | 17.54% |
Cash from operations | -6.84M | 81.35% |
Cash from investing | -199.00K | — |
Cash from financing | -845.00K | 6.53% |
Net change in cash | -7.89M | 79.02% |
Free cash flow | 6.02M | 125.34% |
About
Founded
2013
Website
Employees
32
